• Vaccines, given 4 million doses.

    Dragons: first dose to everyone

  • Covid-19, New Zealand: Auckland again in lockdown for a single infection

Share

February 28, 2021 The Food and Drugs Administration has given the green light to the emergency authorization for the single-dose vaccine against the coronavirus manufactured by Johnson & Johnson.

It is the third anti Covid drug approved in the United States after those developed by Pfizer / BioNTech and Moderna.



The US agency found that the vaccine produced by the US company is "highly effective in preventing severe forms of Covid-19, including those resulting from the new variants".



US President Joe Biden expressed satisfaction but warned that the battle against the pandemic is far from over.

"This is fantastic news for all Americans, as well as an encouraging development in our efforts to end the crisis," Biden said in a statement, warning however that "we cannot let our guard down now or assume that victory is. unavoidable".



Draghi calls for acceleration

In Italy over 4 million (4,222,695) doses of the vaccine have been administered, and 1,391,019 people have received both doses.

Since the beginning of the vaccination campaign (31 December), 5,830,660 vaccine doses have been distributed, of which 4,537,260 Pfizer / BioNTech, 244,600 Moderna and 1,048,800 Astrazeneca.



In detail, the doses were administered to 2,321,326 health workers, 723,295 non-health personnel, 396,057 residents of residential facilities, 579,039 over 80, 60,493 units of the armed forces and 142,485 units of school personnel.



The Prime Minister, Mario Draghi, calls for a change of pace and an acceleration on vaccines. 



At his debut in the European Council, he reiterated that to "slow down" the race of virus mutations, it is necessary to "increase vaccinations" with "coordinated" action at European level, "rapid and transparent", opening up the possibility of giving "priority" to first doses, also in the light of recent scientific literature.



Stocks accumulated amount to 30% of total availability at the time.

They correspond to about two million doses, which can be used immediately.

This is the strategy followed by the United Kingdom.